FID-022

· Fulgent Pharma LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FID-022, covering 2025-09-03 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Study of FID-022 in Solid Tumor Patients